Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Onyx ONE Clear: A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear)

NCT03647475 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03647475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Onyx ONE Clear: A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear)
Lead sponsor
Medtronic Vascular
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2018
Completion date
April 22, 2021
Enrollment
752 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.